Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis
Phase 2
- Conditions
- Endometriosis
- Interventions
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Enteris BioPharma Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT05096065
- Locations
- 🇺🇸
Physician Care Clinical Research, LLC, Sarasota, Florida, United States
🇺🇸Tidewater Clinical Research, Norfolk, Virginia, United States
🇺🇸Complete Healthcare for Women, Columbus, Ohio, United States
A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers
Phase 2
Completed
- Conditions
- Endometriosis
- Interventions
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2022-02-11
- Lead Sponsor
- Enteris BioPharma Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT02807363
- Locations
- 🇨🇦
inVentiv Health Clinique, Inc., Quebec City, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath